CTO in patients with acute myocardial infarction increases long term mortality

Courtesy of Dr. Carlos Fava.

CTO in Patients with Acute Myocardial Infarction Increases MortalityIt has been proved that in a setting of acute myocardial infarction with multivessel lesions, only the culprit vessel must be treated (if there is no hemodynamic compromise) at first, and other severe lesions are to be treated during a second session. However, proper conduct in cases with presence of chronic total occlusion (CTO) is still somewhat unclear.

 

As regards a total population of 836 patients who underwent primary angioplasty, 437 patients (52.3%: 31.3% with 2-vessel disease and 20.9% with 3-vessel disease) presented multivessel disease (MVD) and 146 (17.5%) presented CTO.

 

A comparative analysis was carried out between patients presenting MVD and those with CTO. The latter were more likely to have a history of diabetes, and had a more frequent history of acute myocardial infarction and angioplasty, but a less frequent history of prior myocardial infarction.

 

There was no difference as regards final thrombolysis in myocardial infarction (TIMI) flow 2 or 3.

 

Thirty-day mortality was 4.8% (CTO: 6.8% vs. MVD: 3.8%; p = 0.167); only age was a predictor of mortality (odds ratio [OR]: 1.07; 95% confidence interval [CI]: 1.01-11; p = 0.005).

 

One-year global mortality and cardiac mortality rates for MVD patients were 11% and 10%, respectively, higher than for patients with CTO in both cases (15.8% vs. 8.6%; p = 0.02, and 15% vs. 7.6%; p = 0.001).

 

After a 6-year follow-up, 129 patients (29.7%) in the MVD group had died, more than the number of deaths among patients with CTO (38.6% vs. 25.4%; p = 0.005).

 

CTO was a predictor of long-term mortality (OR: 2.07; 95% CI: 1.3-3.28; p = 0.002), as were age, prior acute myocardial infarction, and angioplasty failure.

 

Conclusion

The presence of CTO is an independent predictor of long-term mortality in ST-elevation myocardial infarction (STEMI) patients treated with primary angioplasty.

 

Editorial Comment

The presence of CTO in STEMI patients warns us about the posibility of more comorbidities and a highly negative impact on their progress.

 

As regards these patients, we need to be stricter in our search for residual ischemia and medical treatment has to be more aggressive. We must also attempt to treat CTO with angioplasty through different strategies, in order to improve survival.

 

More research on this subject is necessary. Randomized studies should be carried out in order to determine the minimum ischemic value necessary for revascularization.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Impact of the Presence of Chronically Occluded Coronary on Long-Term Prognosis of Patients with Acute ST-Segment Elevation Myocardial Infarction.

Reference: Maciej Lesiak et al. Cardiology J 2017;24,2:117-124.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

 

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...